Who Should I Start? Brevin Jordan or Grant Calcaterra


Week 12 Projections

Fant. Pts. Rush. Yds. Rush TD Rec. Rec. Yds. Rec TD
0.0 0.0 0.0 0.0 0.0 0.0

Brevin Jordan News

Brevin Jordan Suffers Torn ACL

Thursday, September 19, 4:50 PM

Houston Texans tight end Brevin Jordan (knee) suffered a torn ACL and will miss the remainder of the 2024 season, according to Aaron Wilson of KPRC2. The 24-year-old will now set his sights on a long recovery process to prepare him for the 2025 season. The former fifth-round selection set a career-high in yards last season with 219. However, Jordan caught just one pass in each of the first two games of the season and was deployed as the No.2 tight end behind Dalton Schultz. Fantasy managers should now expect Schultz to see the lion's share of opportunities at the tight end spot in Houston, while Cade Stover should move up to the No.2 spot and see an increase in work.


Week 12 Projections

Fant. Pts. Rush. Yds. Rush TD Rec. Rec. Yds. Rec TD
1.0 0.0 0.0 0.6 4.2 0.0

Grant Calcaterra News

Grant Calcaterra Sets Season High In Receptions Sunday

Monday, November 4, 9:13 AM

Philadelphia Eagles tight end Grant Calcaterra caught all five of his targets for 30 yards during the team's 28-23 win over the Jacksonville Jaguars. The third-year tight end was involved early in the game having four grabs before halftime, but did little after. Next week will mark the fourth since starter Dallas Goedert (hamstring) was injured against Cleveland and will be his first real shot at making a return to the field. Fantasy managers will need to monitor practice reports during the week, but Calcaterra may move back to his role as the No. 2 option if Goedert is able to put in any practice time this week.


Brevin Jordan vs. Grant Calcaterra

Still trying to decide between Jordan and Calcaterra? Check on the latest news to make sure both players are active and healthy. Our PPR projections show that Brevin Jordan is projected to score 0.0 points this week while Grant Calcaterra is projected to score 1.0 points.